The platelet transcriptome and proteome in Alzheimer's disease and aging: an exploratory cross-sectional study

• Published in: Frontiers in molecular biosciences Vol. 10; p. 1196083
• Main Authors: de Sousa, Diana M Bessa, Poupardin, Rodolphe, Villeda, Saul A, Schroer, Adam B, Fröhlich, Thomas, Frey, Vanessa, Staffen, Wolfgang, Mrowetz, Heike, Altendorfer, Barbara, Unger, Michael S, Iglseder, Bernhard, Paulweber, Bernhard, Trinka, Eugen, Cadamuro, Janne, Drerup, Martin, Schallmoser, Katharina, Aigner, Ludwig, Kniewallner, Kathrin M
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 30.06.2023
• Subjects: aging; Alzheimer’s disease; Molecular Biosciences; platelets; proteomics; transcriptomics; transcriptomics; aging; Alzheimer’s disease; proteomics; platelets
• ISSN: 2296-889X; 2296-889X
• DOI: 10.3389/fmolb.2023.1196083

Alzheimer's disease (AD) and aging are associated with platelet hyperactivity. However, the mechanisms underlying abnormal platelet function in AD and aging are yet poorly understood. To explore the molecular profile of AD and aged platelets, we investigated platelet activation (i.e., CD62P expression), proteome and transcriptome in AD patients, non-demented elderly, and young individuals as controls. AD, aged and young individuals showed similar levels of platelet activation based on CD62P expression. However, AD and aged individuals had a proteomic signature suggestive of increased platelet activation compared with young controls. Transcriptomic profiling suggested the dysregulation of proteolytic machinery involved in regulating platelet function, particularly the ubiquitin-proteasome system in AD and autophagy in aging. The functional implication of these transcriptomic alterations remains unclear and requires further investigation. Our data strengthen the evidence of enhanced platelet activation in aging and provide a first glimpse of the platelet transcriptomic changes occurring in AD.